Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01452984 · ClinicalTrials.gov registry record

Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project

A clinical trial of Non-Melanoma Skin Cancer, sponsored by Abramson Cancer Center at Penn Medicine.

Completed
Registry status
16
Enrollment target
1
Study location

NCT01452984: Completed study of Non-Melanoma Skin Cancer, sponsored by Abramson Cancer Center at Penn Medicine.

NCT01452984 is a study of Non-Melanoma Skin Cancer that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 16 participants, below the 106-participant average among 7 other Non-Melanoma Skin Cancer trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01452984, a study of Non-Melanoma Skin Cancer, has completed, sponsored by Abramson Cancer Center at Penn Medicine.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

Mohs surgery excises non-melanoma skin cancer tumors of the head and neck while preserving maximum healthy tissue, an advantageous characteristic when dealing with the cosmetic and functional cervifacial region. Yet, treatment can result in changes to function and appearance with effects on quality of life. This project uses Grounded Theory to explore the Mohs surgery experience of NMSC patients who have head and neck lesions through interview and observation of the surgical appointment.

Conditions Studied

Study Locations (1)

Pennsylvania

  • Abramson Cancer Center of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2011-07
Est. Completion 2013-12

What the finished NCT01452984 record still lists

NCT01452984 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 106-participant average among 7 other Non-Melanoma Skin Cancer trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Non-Melanoma Skin Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01452984 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01452984 about?

NCT01452984 is a clinical study titled "Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project". Mohs surgery excises non-melanoma skin cancer tumors of the head and neck while preserving maximum healthy tissue, an advantageous characteristic when dealing with the cosmetic and functional cervifacial region. Yet, treatment can result in changes to function and appearance with effects on quality ...

What is the current status of trial NCT01452984?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-07. Estimated completion is 2013-12.

What conditions does trial NCT01452984 study?

This clinical trial studies the following conditions: Non-Melanoma Skin Cancer.

Who is sponsoring clinical trial NCT01452984?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01452984 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-Melanoma Skin Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01452984, the US trial registry maintained by the National Library of Medicine. NCT01452984 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.